Southern Africa Region

Southern Africa Region

Improving health is one of the toughest challenges facing the world today. As a global, innovation-driven biopharmaceutical company, AstraZeneca has a key contribution to make through the discovery, development, manufacturing and commercialisation of medicines for six important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory and inflammation.

AstraZeneca Southern Africa Region (SAR) is currently represented in ten countries i.e. Angola, Botswana, Lesotho, Namibia, Mauritius, Mozambique, Seychelles, Swaziland, Zambia & Zimbabwe, with geographic coverage for Cape Verde, Guinea and Malawi as well. SAR is based in Johannesburg and offers marketing & sales support to the rest of the countries. Namibia is the biggest country in terms of sales, but Angola is the fastest growing and will overtake Namibia in 2014. Angola along with Mozambique are the two Portuguese speaking countries in Africa which brings an amazing opportunity to diversify AZ cultural reach in a continent dominated by English and French speaking countries. Mauritius is also an important hub for AZ business being SSA pilot country for launches due to its fast regulatory approval timeframe; with one of the highest incidence of diabetes in the world is a perfect place for AZ to bring its high quality products in diabetes & CV. With Non communicable diseases becoming an increasing burden in Southern Africa, notably within the area of Cancer, CV/Diabetes and Respiratory, all SAR countries have been able to positively impact their respective communities by introducing AZ products and improving healthcare providers’ knowledge and education. The numbers of doctors in SAR countries is quite limited with very few specialists available which bring an extra pressure to those physicians in terms of having to deal with a great variety of disease areas. The launch of the “Great Minds” program, which allows medical representatives to add value in their doctor visits by offering state of the art pre-recorded medical talks straight from their i-Pads at the doctors own time and convenience shows a high level of innovation and commitment from AZ with an alternative adapted specially for the countries’ needs and supports AZ commitment of making a difference on patients life through great medicines.

Adverse event reporting

Patient Safety – Seeing the Bigger Picture

For all your adverse event reporting please contact:

Sue des Ligneris, on +27 82 456 6598 or
Debra Scott, on +27 79 404 1337 or
Dr Kennedy Njau, on +27 76 323 7000.

Phone: +27 11 797 6243, +27 11 797 6193
Fax: +27 11 797 6019, +27 86 648 4308

Email: PatientSafetySouthAfrica@astrazeneca.com.

Southern Africa Region

Building 2
Northdowns Office Park
17 Georgian Crescent West
BRYANSTON – 2021
Johannesburg – South Africa

Tel:+27 (0) 11 797 6000
Fax: +27 (0) 86 640 1463